Works matching IS 19466234 AND DT 2015 AND VI 7 AND IP 315

Results: 6

  • Unmet needs: Research helps regulators do their jobs.

    Published in:
    Science Translational Medicine, 2015, v. 7, n. 315, p. 1, doi. 10.1126/scitranslmed.aac4369
    By:
    • Altman, Russ B.;
    • Khuri, Natalia;
    • Salit, Marc;
    • Giacomini, Kathleen M.
    Publication type:
    Article

  • Is all cancer therapy immunotherapy?

    Published in:
    Science Translational Medicine, 2015, v. 7, n. 315, p. 1, doi. 10.1126/scitranslmed.aad7661
    By:
    • Belvin, Marcia;
    • Mellman, Ira
    Publication type:
    Article

  • Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.

    Published in:
    Science Translational Medicine, 2015, v. 7, n. 315, p. 1, doi. 10.1126/scitranslmed.aad3231
    By:
    • Furlan, Scott N.;
    • Watkins, Benjamin;
    • Tkachev, Victor;
    • Flynn, Ryan;
    • Cooley, Sarah;
    • Ramakrishnan, Swetha;
    • Singh, Karnail;
    • Giver, Cindy;
    • Hamby, Kelly;
    • Stempora, Linda;
    • Garrett, Aneesah;
    • Jingyang Chen;
    • Betz, Kayla M.;
    • Ziegler, Carly G. K.;
    • Tharp, Gregory K.;
    • Bosinger, Steven E.;
    • Promislow, Daniel E. L.;
    • Miller, Jeffrey S.;
    • Waller, Edmund K.;
    • Blazar, Bruce R.
    Publication type:
    Article

  • Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis.

    Published in:
    Science Translational Medicine, 2015, v. 7, n. 315, p. 1, doi. 10.1126/scitranslmed.aac5608
    By:
    • Headland, Sarah E.;
    • Jones, Hefin R.;
    • Norling, Lucy V.;
    • Kim, Andrew;
    • Souza, Patricia R.;
    • Corsiero, Elisa;
    • Gil, Cristiane D.;
    • Nerviani, Alessandra;
    • Dell’Accio, Francesco;
    • Pitzalis, Costantino;
    • Oliani, Sonia M.;
    • Jan, Lily Y.;
    • Perretti, Mauro
    Publication type:
    Article

  • Type 1 diabetes immunotherapy using polyclonal regulatory T cells.

    Published in:
    Science Translational Medicine, 2015, v. 7, n. 315, p. 1, doi. 10.1126/scitranslmed.aad4134
    By:
    • Bluestone, Jeffrey A.;
    • Buckner, Jane H.;
    • Fitch, Mark;
    • Gitelman, Stephen E.;
    • Gupta, Shipra;
    • Hellerstein, Marc K.;
    • Herold, Kevan C.;
    • Lares, Angela;
    • Lee, Michael R.;
    • Li, Kelvin;
    • Weihong Liu;
    • Long, S. Alice;
    • Masiello, Lisa M.;
    • Vinh Nguyen;
    • Putnam, Amy L.;
    • Rieck, Mary;
    • Sayre, Peter H.;
    • Qizhi Tang
    Publication type:
    Article

  • Trastuzumab emtansine (T-DM1) renders HER2<sup>+</sup> breast cancer highly susceptible to CTLA-4/PD-1 blockade.

    Published in:
    Science Translational Medicine, 2015, v. 7, n. 315, p. 1, doi. 10.1126/scitranslmed.aac4925
    By:
    • Müller, Philipp;
    • Kreuzaler, Matthias;
    • Khan, Tarik;
    • Thommen, Daniela S.;
    • Martin, Kea;
    • Glatz, Katharina;
    • Savic, Spasenija;
    • Harbeck, Nadia;
    • Nitz, Ulrike;
    • Gluz, Oleg;
    • von Bergwelt-Baildon, Michael;
    • Kreipe, Hans;
    • Reddy, Sai;
    • Christgen, Matthias;
    • Zippelius, Alfred
    Publication type:
    Article